Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.
Clavio M, Gatto S, Beltrami G, Quintino S, Canepa L, Pierri I, Galbusera V, Carrara P, Miglino M, Varaldo R, Ballerini F, Venturino C, Cerri R, Risso M, Balleari E, Carella AM, Sessarego M, Ghio R, Bacigalupo A, Gobbi M. Clavio M, et al. Among authors: quintino s. J Exp Clin Cancer Res. 2002 Dec;21(4):481-7. J Exp Clin Cancer Res. 2002. PMID: 12636093
Thalidomide in agnogenic and secondary myelofibrosis.
Canepa L, Ballerini F, Varaldo R, Quintino S, Reni L, Clavio M, Miglino M, Pierri I, Gobbi M. Canepa L, et al. Among authors: quintino s. Br J Haematol. 2001 Nov;115(2):313-5. doi: 10.1046/j.1365-2141.2001.03072.x. Br J Haematol. 2001. PMID: 11703326 Free article. Clinical Trial.
Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
Clavio M, Quintino S, Venturino C, Ballerini F, Varaldo R, Gatto S, Galbusera V, Garrone A, Grasso R, Canepa L, Miglino M, Pierri I, Gobbi M. Clavio M, et al. Among authors: quintino s. J Exp Clin Cancer Res. 2001 Sep;20(3):351-8. J Exp Clin Cancer Res. 2001. PMID: 11718214 Review.
Characterization of ferromagnetic or conductive properties of metallic foreign objects embedded within the human body with magnetic iron detector (MID): Screening patients for MRI.
Gianesin B, Zefiro D, Paparo F, Caminata A, Balocco M, Carrara P, Quintino S, Pinto V, Bacigalupo L, Rollandi GA, Marinelli M, Forni GL. Gianesin B, et al. Among authors: quintino s. Magn Reson Med. 2015 May;73(5):2030-7. doi: 10.1002/mrm.25604. Epub 2015 Mar 26. Magn Reson Med. 2015. PMID: 25820253 Free article.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients.
Pinto VM, Balocco M, Quintino S, Bacigalupo L, Gianesin B, Rizzi M, Malagò R, De Franceschi L, Forni GL. Pinto VM, et al. Among authors: quintino s. Am J Hematol. 2018 Oct;93(10):E338-E340. doi: 10.1002/ajh.25222. Epub 2018 Aug 14. Am J Hematol. 2018. PMID: 30033633 Free article. No abstract available.
18 results